Nashon Ogutu, Silas Agumba, Vincent Moshi, Patrick Onyango, Collins Ouma, Edith Ramaita, Lenson Kariuki, John E Gimnig, Bernard Abong'o, Eric Ochomo
{"title":"PermaNet® Dual 与 Interceptor® G2 和 PermaNet 3.0 在肯尼亚西部西亚县实验棚中的功效比较。","authors":"Nashon Ogutu, Silas Agumba, Vincent Moshi, Patrick Onyango, Collins Ouma, Edith Ramaita, Lenson Kariuki, John E Gimnig, Bernard Abong'o, Eric Ochomo","doi":"10.1186/s12936-024-05157-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pyrethroid-chlorfenapyr nets have shown significant epidemiological impact over pyrethroid-only and pyrethroid plus piperonyl-butoxide (PBO) in Africa. A non-inferiority evaluation of PermaNet<sup>®</sup> Dual, a new chlorfenapyr plus deltamethrin net, compared to Interceptor<sup>®</sup> G2, was conducted in experimental huts in Siaya, Kenya against free-flying pyrethroid-resistant Anopheles funestus.</p><p><strong>Methods: </strong>This study was an experimental hut trial, following a 7 by 7 Latin Square design. Seven treatments and seven sleepers were deployed in the experimental huts daily and rotated weekly and daily, respectively. Mosquitoes were collected every morning between 06:30 h and 08:30 h and were assessed for blood feeding and then monitored for immediate knockdown 1-h post collection and delayed mortality after 72 h. Differences in proportional outcomes were analysed using the blocked logistic regression model, while differences in numerical outcomes were analysed using the negative binomial regression model. Non-inferiority determination was performed based on World Health Organization (WHO) protocol.</p><p><strong>Results: </strong>Mortality at 72 h was 30.2% for PermaNet 3.0, 44.4% for the Interceptor<sup>®</sup> G2 and 49.2% for the PermaNet<sup>®</sup> Dual. Blood feeding was highest with PermaNet<sup>®</sup> Dual at 15%, and least with PermaNet<sup>®</sup> 3.0 at 10%. PermaNet<sup>®</sup> Dual and Interceptor<sup>®</sup> G2 had no significant differences in mortality (OR = 1.10, 95% CI 1.00-1.20) or blood feeding (OR = 1.18, 95% CI 1.04-1.33) and the lower confidence bounds were within the non-inferiority margins but for blood feeding, non-inferiority was relatively high to the upper 95% confidence bound. PermaNet<sup>®</sup> Dual was non-inferior to the Interceptor<sup>®</sup> G2 and superior to the PermaNet<sup>®</sup> 3.0 nets in causing mortality but inferior to PermaNet <sup>®</sup>3.0 in blood feeding inhibition of the vectors.</p><p><strong>Conclusion: </strong>PermaNet<sup>®</sup> Dual met the WHO criteria for non-inferiority to Interceptor<sup>®</sup> G2 and may be considered for deployment for public health use against pyrethroid-resistant Anopheles vectors of malaria.</p>","PeriodicalId":18317,"journal":{"name":"Malaria Journal","volume":"23 1","pages":"326"},"PeriodicalIF":2.4000,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11531690/pdf/","citationCount":"0","resultStr":"{\"title\":\"Efficacy of PermaNet<sup>®</sup> Dual compared to Interceptor<sup>®</sup> G2 and PermaNet 3.0 in experimental huts in Siaya County, western Kenya.\",\"authors\":\"Nashon Ogutu, Silas Agumba, Vincent Moshi, Patrick Onyango, Collins Ouma, Edith Ramaita, Lenson Kariuki, John E Gimnig, Bernard Abong'o, Eric Ochomo\",\"doi\":\"10.1186/s12936-024-05157-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Pyrethroid-chlorfenapyr nets have shown significant epidemiological impact over pyrethroid-only and pyrethroid plus piperonyl-butoxide (PBO) in Africa. A non-inferiority evaluation of PermaNet<sup>®</sup> Dual, a new chlorfenapyr plus deltamethrin net, compared to Interceptor<sup>®</sup> G2, was conducted in experimental huts in Siaya, Kenya against free-flying pyrethroid-resistant Anopheles funestus.</p><p><strong>Methods: </strong>This study was an experimental hut trial, following a 7 by 7 Latin Square design. Seven treatments and seven sleepers were deployed in the experimental huts daily and rotated weekly and daily, respectively. Mosquitoes were collected every morning between 06:30 h and 08:30 h and were assessed for blood feeding and then monitored for immediate knockdown 1-h post collection and delayed mortality after 72 h. Differences in proportional outcomes were analysed using the blocked logistic regression model, while differences in numerical outcomes were analysed using the negative binomial regression model. Non-inferiority determination was performed based on World Health Organization (WHO) protocol.</p><p><strong>Results: </strong>Mortality at 72 h was 30.2% for PermaNet 3.0, 44.4% for the Interceptor<sup>®</sup> G2 and 49.2% for the PermaNet<sup>®</sup> Dual. Blood feeding was highest with PermaNet<sup>®</sup> Dual at 15%, and least with PermaNet<sup>®</sup> 3.0 at 10%. PermaNet<sup>®</sup> Dual and Interceptor<sup>®</sup> G2 had no significant differences in mortality (OR = 1.10, 95% CI 1.00-1.20) or blood feeding (OR = 1.18, 95% CI 1.04-1.33) and the lower confidence bounds were within the non-inferiority margins but for blood feeding, non-inferiority was relatively high to the upper 95% confidence bound. PermaNet<sup>®</sup> Dual was non-inferior to the Interceptor<sup>®</sup> G2 and superior to the PermaNet<sup>®</sup> 3.0 nets in causing mortality but inferior to PermaNet <sup>®</sup>3.0 in blood feeding inhibition of the vectors.</p><p><strong>Conclusion: </strong>PermaNet<sup>®</sup> Dual met the WHO criteria for non-inferiority to Interceptor<sup>®</sup> G2 and may be considered for deployment for public health use against pyrethroid-resistant Anopheles vectors of malaria.</p>\",\"PeriodicalId\":18317,\"journal\":{\"name\":\"Malaria Journal\",\"volume\":\"23 1\",\"pages\":\"326\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-11-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11531690/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Malaria Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12936-024-05157-w\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaria Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12936-024-05157-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Efficacy of PermaNet® Dual compared to Interceptor® G2 and PermaNet 3.0 in experimental huts in Siaya County, western Kenya.
Background: Pyrethroid-chlorfenapyr nets have shown significant epidemiological impact over pyrethroid-only and pyrethroid plus piperonyl-butoxide (PBO) in Africa. A non-inferiority evaluation of PermaNet® Dual, a new chlorfenapyr plus deltamethrin net, compared to Interceptor® G2, was conducted in experimental huts in Siaya, Kenya against free-flying pyrethroid-resistant Anopheles funestus.
Methods: This study was an experimental hut trial, following a 7 by 7 Latin Square design. Seven treatments and seven sleepers were deployed in the experimental huts daily and rotated weekly and daily, respectively. Mosquitoes were collected every morning between 06:30 h and 08:30 h and were assessed for blood feeding and then monitored for immediate knockdown 1-h post collection and delayed mortality after 72 h. Differences in proportional outcomes were analysed using the blocked logistic regression model, while differences in numerical outcomes were analysed using the negative binomial regression model. Non-inferiority determination was performed based on World Health Organization (WHO) protocol.
Results: Mortality at 72 h was 30.2% for PermaNet 3.0, 44.4% for the Interceptor® G2 and 49.2% for the PermaNet® Dual. Blood feeding was highest with PermaNet® Dual at 15%, and least with PermaNet® 3.0 at 10%. PermaNet® Dual and Interceptor® G2 had no significant differences in mortality (OR = 1.10, 95% CI 1.00-1.20) or blood feeding (OR = 1.18, 95% CI 1.04-1.33) and the lower confidence bounds were within the non-inferiority margins but for blood feeding, non-inferiority was relatively high to the upper 95% confidence bound. PermaNet® Dual was non-inferior to the Interceptor® G2 and superior to the PermaNet® 3.0 nets in causing mortality but inferior to PermaNet ®3.0 in blood feeding inhibition of the vectors.
Conclusion: PermaNet® Dual met the WHO criteria for non-inferiority to Interceptor® G2 and may be considered for deployment for public health use against pyrethroid-resistant Anopheles vectors of malaria.
期刊介绍：
Malaria Journal is aimed at the scientific community interested in malaria in its broadest sense. It is the only journal that publishes exclusively articles on malaria and, as such, it aims to bring together knowledge from the different specialities involved in this very broad discipline, from the bench to the bedside and to the field.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
